MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    The Efficacy of Neuromodulation for Motor Recovery in Children with Hemiparesis Due to Perinatal Stroke: A Systematic Review and Meta-Analysis.

    I. Andrade, A. de Almeida (Vitória da Conquista, Brazil)

    Objective: To assess the effectiveness of neurostimulation in enhancing motor function in children with perinatal stroke and hemiparetic cerebral palsy. Background: Neuromodulation techniques, including repetitive…
  • 2025 International Congress

    Understanding Referral Patterns to a Pediatric Movement Disorders Clinic: A Quality Improvement Project

    A. Leblanc-Millar, C. Gorodetsky (Toronto, Canada)

    Objective: To implement a Quality Improvement initiative analyzing referral patterns to an Ontario pediatric movement disorder clinic to develop a better understanding of the acceptance,…
  • 2025 International Congress

    GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

    T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To describe the clinical presentation, diagnostic evaluation, and genetic findings in a 7-year-old male with a hyperkinetic movement disorder associated with a novel GNAI1…
  • 2025 International Congress

    Exploring the Role of Aperiodic and Periodic Spectral Activity in Guiding Deep Brain Stimulation Electrode Selection for Childhood Dystonia

    T. Larsh, S. Vadivelu, J. Skoch, T. Lipps, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To evaluate the potential of aperiodic and periodic neural activity in guiding clinical deep brain stimulation (DBS) programming for children with dystonia. Background: DBS…
  • 2025 International Congress

    Spectrum and Evolution of Movement Disorder Phenomenology in a Pediatric Powassan Encephalitis Case Series

    R. Lindsay, K. Yang, V. Quiroz, R. Srouji, D. Ebrahimi-Fakhari (Calgary, Canada)

    Objective: The Powassan virus is a rare neurotropic, tick-borne arbovirus associated with meningoencephalitis. Despite the virus’s known predilection for the basal ganglia, there are no…
  • 2025 International Congress

    Wilson’s Disease with Hereditary Hemorrhagic Telangiectasia and Pituitary Microadenoma: A Case Report

    D. Dai, L. Li, X. Xu (Urumqi, China)

    Objective: To report a case of a young female patient with Wilson's disease, hereditary hemorrhagic telangiectasia (HHT), and pituitary microadenoma, and to enhance the understanding…
  • 2025 International Congress

    Management of Grisel’s Syndrome with Botulinum Toxin: A Case Report

    L. Kenjaeva, A. Azimov, G. Kendjaeva (Tashkent, Uzbekistan)

    Objective: To present a case of Grisel’s syndrome (GS), highlighting challenges and the efficacy of botulinum toxin therapy in treatment. Background: Grisel’s syndrome (GS) is…
  • 2025 International Congress

    Genetic and clinical spectrum of pediatric hyperkinetic movement disorders in a Spanish tertiary center

    JD. Ortigoza Escobar, B. Antomil Guerrero, L. Marti-Sanchez, D. Yubero, C. Xiol Viñas, A. Alcalá Sanmartín, C. Hernando Davalillo, J. Armstrong, L. Martorell (Barcelona, Spain)

    Objective: To investigate the genetic etiology of pediatric hyperkinetic movement disorders (PMDs), characterize their associated phenotypes, comorbidities, and neuroimaging findings, and evaluate the impact of…
  • 2025 International Congress

    The Phenotypic Spectrum of ATP1A3-Related Disorders: A Brazilian Cohort

    V. Procaci, A. Gomes, R. Hora, P. Lima, J. Ferrer, D. Maia, F. Cardoso, H. Linden, M. Krueger, E. Leão, T. Tonholo Silva, P. Nóbrega, O. Barsottini, J. Pedroso (São Paulo, Brazil)

    Objective: To describe a case series of patients with ATP1A3 variants, analyzing their phenotypic presentation and genetic characteristics in Brazil. Background: ATP1A3-related disorders exhibit a complex…
  • 2025 International Congress

    Design and Outcome Measures of BRAVE, a Phase 3 Study of Omaveloxolone in Pediatric Patients With Friedreich Ataxia

    D. Lynch, M. Delatycki, M. França, A. Durr, E. Bertini, S. Perlman, A. Arizpe, R. Domingo-Horne, S. Fradette, S. Sinks, M. Murai, N. Folschweiller (Philadelphia, USA)

    Objective: This phase 3 randomized controlled trial will assess the efficacy and safety of omaveloxolone in children aged 2 to <16 years. Background: Omaveloxolone is…
  • « Previous Page
  • 1
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley